Pharma's Transformative Journeys: Mergers, Acquisitions, and New Frontiers
Published on: May 2, 2026, 2:31 a.m. | Source: Devdiscourse
In the health industry, significant moves are being made including LEO Pharma's acquisition of Replay and Archimed’s plan to take Esperion Therapeutics private. Meanwhile, Bristol Myers Squibb beats profit expectations, and the FDA introduces regulations impacting compounding weight-loss drugs. Notable shifts include discussions over drug patents and Medicare Advantage benefits.
